BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20715818)

  • 21. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
    Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors.
    Chimenti F; Fioravanti R; Bolasco A; Chimenti P; Secci D; Rossi F; Yáñez M; Orallo F; Ortuso F; Alcaro S; Cirilli R; Ferretti R; Sanna ML
    Bioorg Med Chem; 2010 Feb; 18(3):1273-9. PubMed ID: 20045650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors.
    Gaspar A; Silva T; Yáñez M; Vina D; Orallo F; Ortuso F; Uriarte E; Alcaro S; Borges F
    J Med Chem; 2011 Jul; 54(14):5165-73. PubMed ID: 21696156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives.
    Chimenti F; Carradori S; Secci D; Bolasco A; Bizzarri B; Chimenti P; Granese A; Yáñez M; Orallo F
    Eur J Med Chem; 2010 Feb; 45(2):800-4. PubMed ID: 19926363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.
    Secci D; Carradori S; Bolasco A; Chimenti P; Yáñez M; Ortuso F; Alcaro S
    Eur J Med Chem; 2011 Oct; 46(10):4846-52. PubMed ID: 21872365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoamine oxidase.
    Leonetti F; Capaldi C; Pisani L; Nicolotti O; Muncipinto G; Stefanachi A; Cellamare S; Caccia C; Carotti A
    J Med Chem; 2007 Oct; 50(20):4909-16. PubMed ID: 17824599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.
    Matos MJ; Viña D; Picciau C; Orallo F; Santana L; Uriarte E
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5053-5. PubMed ID: 19628387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B.
    La Regina G; Silvestri R; Gatti V; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
    Bioorg Med Chem; 2008 Nov; 16(22):9729-40. PubMed ID: 18951803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones.
    Valente S; Tomassi S; Tempera G; Saccoccio S; Agostinelli E; Mai A
    J Med Chem; 2011 Dec; 54(23):8228-32. PubMed ID: 22017497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of an immobilised amylose-based chiral stationary phase to the development of new monoamine oxidase B inhibitors.
    Sanna ML; Maccioni E; Vigo S; Faggi C; Cirilli R
    Talanta; 2010 Jun; 82(1):426-31. PubMed ID: 20685489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Frontiers in Selective Human MAO-B Inhibitors.
    Carradori S; Silvestri R
    J Med Chem; 2015 Sep; 58(17):6717-32. PubMed ID: 25915162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Santana L; González-Díaz H; Quezada E; Uriarte E; Yáñez M; Viña D; Orallo F
    J Med Chem; 2008 Nov; 51(21):6740-51. PubMed ID: 18834112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B.
    Alcaro S; Gaspar A; Ortuso F; Milhazes N; Orallo F; Uriarte E; Yáñez M; Borges F
    Bioorg Med Chem Lett; 2010 May; 20(9):2709-12. PubMed ID: 20382016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of 4-substituted 1,2,3-triazoles as novel oxazolidinone antibacterial agents with reduced activity against monoamine oxidase A.
    Reck F; Zhou F; Girardot M; Kern G; Eyermann CJ; Hales NJ; Ramsay RR; Gravestock MB
    J Med Chem; 2005 Jan; 48(2):499-506. PubMed ID: 15658863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.
    Sahoo A; Yabanoglu S; Sinha BN; Ucar G; Basu A; Jayaprakash V
    Bioorg Med Chem Lett; 2010 Jan; 20(1):132-6. PubMed ID: 19945874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new therapeutic approach in Alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics.
    Gökhan-Kelekçi N; Yabanoğlu S; Küpeli E; Salgin U; Ozgen O; Uçar G; Yeşilada E; Kendi E; Yeşilada A; Bilgin AA
    Bioorg Med Chem; 2007 Sep; 15(17):5775-86. PubMed ID: 17611112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches.
    Catto M; Nicolotti O; Leonetti F; Carotti A; Favia AD; Soto-Otero R; Méndez-Alvarez E; Carotti A
    J Med Chem; 2006 Aug; 49(16):4912-25. PubMed ID: 16884303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.
    Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V
    Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chalcones: a valid scaffold for monoamine oxidases inhibitors.
    Chimenti F; Fioravanti R; Bolasco A; Chimenti P; Secci D; Rossi F; Yáñez M; Orallo F; Ortuso F; Alcaro S
    J Med Chem; 2009 May; 52(9):2818-24. PubMed ID: 19378991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoamine oxidase A and B inhibitory activities of 3,5-diphenyl-1,2,4-triazole substituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives.
    Bekircan O; Danış Ö; Şahin ME; Çetin M
    Bioorg Chem; 2022 Jan; 118():105493. PubMed ID: 34814086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.